|
TRIM6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.212380E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.823840E-04 |
| Normal-vs-Stage2 |
3.74020000000197E-05 |
| Normal-vs-Stage3 |
5.407500E-04 |
| Normal-vs-Stage4 |
8.08280000000883E-05 |
| Stage1-vs-Stage2 |
8.186100E-02 |
| Stage1-vs-Stage3 |
8.629800E-01 |
| Stage1-vs-Stage4 |
3.056400E-01 |
| Stage2-vs-Stage3 |
1.982360E-01 |
| Stage2-vs-Stage4 |
5.923800E-01 |
| Stage3-vs-Stage4 |
4.062400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.594170E-04 |
| Normal-vs-AfricanAmerican |
1.59287000000008E-05 |
| Normal-vs-Asian |
4.100300E-02 |
| Caucasian-vs-AfricanAmerican |
1.845530E-02 |
| Caucasian-vs-Asian |
4.971000E-01 |
| AfricanAmerican-vs-Asian |
7.923900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.83370000000394E-05 |
| Normal-vs-Female |
3.585900E-04 |
| Male-vs-Female |
1.021820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.80829999996135E-06 |
| Normal-vs-Age(41-60Yrs) |
1.382150E-04 |
| Normal-vs-Age(61-80Yrs) |
1.439020E-04 |
| Normal-vs-Age(81-100Yrs) |
4.271700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.078600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.002370E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.941900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.529200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.797400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.777000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.841800E-03 |
| Normal-vs-Grade 2 |
3.608300E-04 |
| Normal-vs-Grade 3 |
1.970860E-04 |
| Normal-vs-Grade 4 |
3.14170000004221E-06 |
| Grade 1-vs-Grade 2 |
5.431200E-01 |
| Grade 1-vs-Grade 3 |
3.221600E-01 |
| Grade 1-vs-Grade 4 |
2.629700E-02 |
| Grade 2-vs-Grade 3 |
6.294600E-01 |
| Grade 2-vs-Grade 4 |
3.360400E-03 |
| Grade 3-vs-Grade 4 |
5.241300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.962500E-03 |
| Normal-vs-ccB subtype |
1.67440999999657E-05 |
| ccA subtype-vs-ccB subtype |
1.88298000000087E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.624800E-04 |
| Normal-vs-N1 |
1.290300E-02 |
| N0-vs-N1 |
7.348800E-01 |
|
|
